Professor
Institut Universitaire du Cancer de Toulouse-Oncopole
Toulouse, Midi-Pyrenees, France
Jill Corre, PharmD, PhD, graduated from the Pharmaceutical Faculty of Tours in France. She moved to Toulouse where she completed his training as a resident in Medical Biology and specialized in Hematology in the University Hospital. In 2007, she joined the staff of Hematology Laboratory of the University Toulouse Hospital where she is now professor. Her doctoral thesis was on myeloma microenvironment, in particular on mesenchymal stromal cells. In 2012, she also joined Professor Hervé Avet-Loiseau in the Unit for Genomics in Myeloma, which is now located in the University Cancer Institute of Toulouse Oncopole. Her research activity takes place in the team Pharmacogenomic of myeloma, from the Cancer Research Center of Toulouse. She is currently a member of the Intergroupe Francophone du Myélome and from International Myeloma Society.
Disclosure information not submitted.
Wednesday, September 25, 2024
11:42 AM – 11:54 AM East Coast USA Time
New classification for identifying HR Myeloma based on cytogenetic abnormalities
Thursday, September 26, 2024
9:00 AM – 9:10 AM East Coast USA Time
Thursday, September 26, 2024
10:00 AM – 10:30 AM East Coast USA Time